CN112236416A
2019-06-03
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
CN112004803A
2019-04-22
Process for preparing regioselective N-alkyltriazoles
US2020000824A1
2018-08-22
Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
US10231983B1
2018-08-22
Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
AU2018289307A1
2018-06-18
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
US2018325891A1
2018-05-10
Octahydro azadecalin formulations
CN110520121A
2018-03-30
Glucocorticoid receptor modulator treats cervical carcinoma
EP3592358A1
2018-03-08
Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors
US2018071255A1
2017-09-07
Glucocorticoid receptor modulators to treat pancreatic cancer
US2017281651A1
2017-06-19
Concomitant administration of glucocorticoid receptor modulators and cyp3a or steroidogenesis inhibitors
KR20180116372A
2017-02-28
Use of glucocorticoid receptor modulators to enhance checkpoint inhibitors
CA3011728A1
2017-01-18
Differential diagnosis of ectopic cushing's syndrome
CA2994422A1
2016-08-12
Method for differentially diagnosing acth-dependent cushing's syndrome
US2018291451A1
2016-05-18
Methods for diagnosing and assessing treatment for Cushing's syndrome
US2016310507A1
2016-04-20
Optimizing mifepristone levels for cushing's patients
EP3277281A1
2016-03-30
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
AU2016226451A1
2016-02-25
Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
SG11201703024VA
2015-10-14
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
CA2948575A1
2015-05-18
Systems and methods of managing treatment of a chronic condition by symptom tracking
WO2015077537A1
2014-11-21
Heteroaryl-ether fused azadecalin glucocorticoid receptor modulators
